| Primary |
| Product Used For Unknown Indication |
27.3% |
| Hypertension |
23.5% |
| Drug Use For Unknown Indication |
14.2% |
| Cardiac Failure Congestive |
6.2% |
| Type 2 Diabetes Mellitus |
4.5% |
| Cardiac Failure |
3.8% |
| Cardiac Failure Chronic |
3.7% |
| Atrial Fibrillation |
2.7% |
| Myocardial Infarction |
2.0% |
| Cardiomyopathy |
1.5% |
| Blood Pressure Increased |
1.4% |
| Coronary Artery Disease |
1.4% |
| Blood Pressure |
1.3% |
| Diabetes Mellitus |
1.2% |
| Prophylaxis |
1.1% |
| Cardiac Disorder |
1.1% |
| Cardiovascular Event Prophylaxis |
0.8% |
| Insomnia |
0.8% |
| Hyperlipidaemia |
0.8% |
| Congestive Cardiomyopathy |
0.7% |
|
| Syncope |
10.7% |
| Hypotension |
7.1% |
| Dizziness |
6.9% |
| Completed Suicide |
6.4% |
| Fatigue |
6.4% |
| Drug Ineffective |
5.6% |
| Malaise |
5.3% |
| Bradycardia |
4.8% |
| Renal Failure Acute |
4.8% |
| Nausea |
4.6% |
| Somnolence |
4.6% |
| Vomiting |
4.3% |
| Dyspnoea |
4.1% |
| Hyperkalaemia |
4.1% |
| Palpitations |
3.8% |
| Renal Failure |
3.6% |
| Pruritus |
3.3% |
| Therapeutic Response Unexpected With Drug Substitution |
3.3% |
| Ventricular Tachycardia |
3.3% |
| Death |
3.1% |
|
| Secondary |
| Product Used For Unknown Indication |
24.0% |
| Hypertension |
19.8% |
| Drug Use For Unknown Indication |
16.1% |
| Cardiac Failure |
6.5% |
| Cardiac Failure Chronic |
4.0% |
| Cardiac Failure Congestive |
4.0% |
| Type 2 Diabetes Mellitus |
3.2% |
| Myocardial Infarction |
3.2% |
| Atrial Fibrillation |
2.6% |
| Blood Pressure Increased |
2.1% |
| Diabetes Mellitus |
1.9% |
| Prophylaxis |
1.8% |
| Hyperlipidaemia |
1.6% |
| Insomnia |
1.4% |
| Cardiac Disorder |
1.4% |
| Suicide Attempt |
1.3% |
| Acute Coronary Syndrome |
1.3% |
| Arrhythmia |
1.2% |
| Blood Pressure |
1.2% |
| Cardiovascular Disorder |
1.2% |
|
| Completed Suicide |
15.4% |
| Syncope |
10.3% |
| Weight Decreased |
9.2% |
| Renal Failure Acute |
6.8% |
| Hypotension |
6.4% |
| Toxicity To Various Agents |
6.0% |
| Vomiting |
5.1% |
| Death |
4.5% |
| Interstitial Lung Disease |
3.9% |
| Hyperkalaemia |
3.5% |
| Fatigue |
3.3% |
| Overdose |
3.3% |
| Pain In Extremity |
3.1% |
| Cardiac Failure |
2.9% |
| Poisoning |
2.9% |
| Rash |
2.9% |
| Dizziness |
2.7% |
| Dyspnoea |
2.7% |
| Renal Impairment |
2.7% |
| Rhabdomyolysis |
2.7% |
|
| Concomitant |
| Product Used For Unknown Indication |
31.6% |
| Drug Use For Unknown Indication |
15.9% |
| Hypertension |
14.6% |
| Diabetes Mellitus |
4.2% |
| Cardiac Failure |
4.2% |
| Atrial Fibrillation |
4.0% |
| Cardiac Disorder |
3.2% |
| Rheumatoid Arthritis |
2.7% |
| Prophylaxis |
2.6% |
| Type 2 Diabetes Mellitus |
2.3% |
| Blood Cholesterol Increased |
2.3% |
| Pain |
1.9% |
| Cardiac Failure Congestive |
1.6% |
| Coronary Artery Disease |
1.4% |
| Cardiac Failure Chronic |
1.4% |
| Depression |
1.3% |
| Chronic Obstructive Pulmonary Disease |
1.3% |
| Gastrooesophageal Reflux Disease |
1.2% |
| Hyperlipidaemia |
1.2% |
| Blood Pressure |
1.1% |
|
| Vomiting |
10.0% |
| Renal Failure Acute |
8.1% |
| Weight Decreased |
7.0% |
| Death |
6.5% |
| Myocardial Infarction |
5.4% |
| Flushing |
5.4% |
| Pneumonia |
5.2% |
| Weight Increased |
5.0% |
| Pruritus |
4.9% |
| Drug Ineffective |
4.5% |
| Renal Failure |
4.5% |
| Dyspnoea |
4.4% |
| Cardiac Failure |
4.0% |
| Thrombocytopenia |
4.0% |
| Pain |
3.9% |
| Nausea |
3.8% |
| Urinary Tract Infection |
3.7% |
| Rhabdomyolysis |
3.4% |
| Ventricular Tachycardia |
3.2% |
| International Normalised Ratio Increased |
3.1% |
|
| Interacting |
| Product Used For Unknown Indication |
22.8% |
| Hypertension |
22.5% |
| Drug Use For Unknown Indication |
9.4% |
| Type 2 Diabetes Mellitus |
7.9% |
| Atrial Fibrillation |
5.3% |
| Cardiac Failure Congestive |
4.7% |
| Arrhythmia |
3.5% |
| Prophylaxis |
2.6% |
| Prophylaxis Against Gastrointestinal Ulcer |
2.6% |
| Pain |
2.3% |
| Cardiac Failure |
2.0% |
| Cardiac Disorder |
1.8% |
| Chronic Obstructive Pulmonary Disease |
1.8% |
| Erectile Dysfunction |
1.8% |
| Myeloproliferative Disorder |
1.8% |
| Renal Transplant |
1.8% |
| Disseminated Tuberculosis |
1.5% |
| Extrasystoles |
1.5% |
| Gout |
1.5% |
| Anaphylactic Reaction |
1.2% |
|
| Drug Interaction |
15.2% |
| Fatigue |
7.6% |
| Hyperkalaemia |
7.6% |
| Hypoglycaemia |
7.6% |
| Rash |
6.3% |
| Transaminases Increased |
6.3% |
| Hypertension |
5.1% |
| Pneumonia |
5.1% |
| Vertigo |
5.1% |
| Vomiting |
5.1% |
| Blood Pressure Abnormal |
3.8% |
| Renal Failure Acute |
3.8% |
| Tremor |
3.8% |
| Catheterisation Cardiac |
2.5% |
| Dyspnoea |
2.5% |
| Frustration |
2.5% |
| Hepatitis Cholestatic |
2.5% |
| Oedema |
2.5% |
| Rhabdomyolysis |
2.5% |
| Torsade De Pointes |
2.5% |
|
